Primary Category:
Treatment Protocols
Disease Category:
Colon, Gastrointestinal
Status:
Open
Phase II/III Study of Circulating Tumor DNA as a Predictive Biomarker in Adjuvant Chemotherapy in Patients with Stage IIA Colon Cancer (COBRA)
NCT#04068103
GI005 is suspended to accrual effective December 28, 2020.
